Boceprevir for chronic HCV genotype 1 infection [1]

New England Journal of Medicine

Volumn 365, Issue 2, 2011, Pages 176-178

  Limaye, Alpna R ^a   Draganov, Peter V ^a   Cabrera, Roniel ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOCEPREVIR; ERYTHROPOIETIN; TELAPREVIR; INTERLEUKIN 28B; PEGINTERFERON; RIBAVIRIN; ALPHA2B INTERFERON; ANTIVIRUS AGENT; DRUG DERIVATIVE; MACROGOL DERIVATIVE; N (3 AMINO 1 (CYCLOBUTYLMETHYL) 2,3 DIOXOPROPYL) 3 (2 ((((1,1 DIMETHYLETHYL)AMINO)CARBONYL)AMINO) 3,3 DIMETHYL 1 OXOBUTYL) 6,6 DIMETHYL 3 AZABICYCLO(3.1.0)HEXAN 2 CARBOXAMIDE; N-(3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL)-3-(2-((((1,1-DIMETHYLETHYL)AMINO)CARBONYL)AMINO)-3,3-DIMETHYL-1-OXOBUTYL)-6,6-DIMETHYL-3-AZABICYCLO(3.1.0)HEXAN-2-CARBOXAMIDE; OLIGOPEPTIDE; PEGINTERFERON ALPHA2B; PROLINE; SERINE PROTEINASE INHIBITOR; IL28B PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ANEMIA; DRUG WITHDRAWAL; GENOTYPE; HEPATITIS C; HUMAN; LETTER; PRIORITY JOURNAL; GENE; GENETIC VARIABILITY; INOSINE TROPHOSPHATASE GENE; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; HEPATITIS C VIRUS; NOTE; VIRUS LOAD; GENETIC POLYMORPHISM; GENETICS;

ANEMIA; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; OLIGOPEPTIDES; POLYETHYLENE GLYCOLS; PROLINE; RIBAVIRIN; SERINE PROTEINASE INHIBITORS; VIRAL LOAD; INTERLEUKINS; POLYMORPHISM, GENETIC;

EID: 79960206940     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1105515     Document Type: Letter

References (5)

1. Poordad F, McCone J Jr, Bacon BR, et al. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 2011;364:1195-206.
2. Bacon BR, Gordon SC, Lawitz E, et al. Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med 2011;364:1207-17.
3. McHutchison JG, Everson GT, Gordon SC, et al. Telaprevir with pegylated interferon and ribavirin for chronic HCV genotype 1 infection. N Engl J Med 2009;360:1827-38. [Erratum, N Engl J Med 2009;361:1516.]
4. McHutchison JG, Manns MP, Muir AJ, et al. Telaprevir for previously treated chronic HCV infection. N Engl J Med 2010; 362:1292-303. [Erratum, N Engl J Med 2010;362:1647.]
5. Jacobson IM, McHutchison JG, Dusheiko GM, et al. Telaprevir in combination with peginterferon and ribavirin in genotype 1 HCV treatment-naive patients: final results of Phase 3 ADVANCE study. Hepatology 2010;52:Suppl:427A. abstract.